Avantor (AVTR) Stock Price
Avantor Price
Avantor (AVTR) Stock | ISIN US05352A1007 | WKN A2PJN6. The current Avantor stock price is 9.86 USD (2026). Revenue is 6.62 B USD. Net income is 548.29 M USD. The P/E ratio is 12.25. Market capitalization is 6.73 B USD. Avantor operates in the Health sector.
Avantor stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Avantor over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Avantor stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Avantor's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Avantor Price |
|---|
Avantor Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Avantor Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Avantor generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Avantor retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Avantor's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Avantor has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Avantor's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Avantor stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Avantor Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Avantor business model & stock analysis
Avantor SWOT Analysis
Strengths
- Avantor Inc has a strong market presence and brand recognition in the scientific research and pharmaceutical industries.
- The company has a wide range of high-quality products and solutions, offering a comprehensive portfolio to its customers.
- Avantor Inc has a well-established global distribution network, enabling it to reach customers in various regions efficiently.
Weaknesses
- Avantor Inc heavily relies on a few key customers, which may expose the company to risks if those customers reduce their orders or switch to competitors.
- The company has a complex supply chain, involving multiple suppliers and logistics, which can lead to challenges in managing inventory and timely order fulfillment.
- Avantor Inc's high dependence on raw materials and supplies from external sources exposes it to potential disruptions in the supply chain.
Opportunities
- Growing demand for scientific research and advancements in the pharmaceutical industry provide opportunities for Avantor Inc to expand its customer base and increase sales.
- The company can capitalize on emerging markets, such as Asia-Pacific, where there is increasing focus on research and development in various industries.
- Avantor Inc can explore strategic partnerships or acquisitions to enhance its product offerings and expand its market reach.
Threats
- Intense competition in the scientific research and pharmaceutical industries poses a threat to Avantor Inc's market share and profitability.
- Changes in government regulations and policies related to the research and pharmaceutical sectors can impact the company's operations and profitability.
- Economic downturns or financial instability in key markets may affect customer spending and demand for Avantor Inc's products.
Avantor Segments
Avantor Revenue by Segment (1/4)
3 Years
5 Years
Max
Details
Avantor Revenue by Segment (2/4)
3 Years
5 Years
Max
Details
Avantor Revenue by Segment (3/4)
3 Years
5 Years
Max
Details
Avantor Revenue by Segment (4/4)
3 Years
5 Years
Max
Details
Avantor Eulerpool Fair Value
Avantor historical P/E ratio, EBIT multiple, and P/S ratio
Avantor annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Avantor shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Avantor Earnings Estimates
Avantor Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/29/2026 | 0.16USD | 1.57 BUSD | 2026 Q1 |
| 4/24/2026 | 0.16USD | 1.57 BUSD | 2026 Q1 |
| 2/11/2026 | 0.22USD | 1.67 BUSD | 2025 Q4 |
| 1/29/2026 | 0.22USD | 1.67 BUSD | 2025 Q4 |
| 4/26/2024 | 0.25USD | 1.75 BUSD | 2024 Q1 |
| 2/1/2024 | 0.23USD | 1.73 BUSD | 2023 Q4 |
| 7/26/2023 | 0.37USD | 1.92 BUSD | 2023 Q2 |
| 4/26/2023 | 0.36USD | 1.91 BUSD | 2023 Q1 |
| 2/1/2023 | 0.31USD | 1.82 BUSD | 2022 Q4 |
| 10/28/2022 | 0.34USD | 1.88 BUSD | 2022 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Avantor stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Avantor shareholder structure
| % | Name |
|---|---|
17.16347% | |
9.48797% | |
7.84739% | |
4.88039% | |
4.711% | |
3.43615% | |
3.0057% | |
2.963% | |
2.40606% | |
2.21462% |
Avantor Executives and Management Board
Mr. R. Brent Jones
(55)Chief Financial Officer, Executive Vice President
Mr. Benoit Gourdier
(54)Executive Vice President - Bioscience Production
Mr. Claudius Sokenu
(57)Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary
Mr. Gregory Summe
(68)Independent Chairman of the Board
Mr. Joseph Massaro
(55)Independent Director
Avantor Supply Chain
Frequently asked questions about Avantor
Avantor Inc. operates as a global provider of products and services for customers in the life sciences and advanced technologies industries. The company's business model focuses on offering a comprehensive range of high-quality products, including chemicals, bio-reagents, consumables, equipment, instruments, and more. Avantor serves diverse markets such as pharmaceuticals, biotechnology, healthcare, diagnostics, academia, research, and electronics. With a strong emphasis on innovation, Avantor strives to deliver customized solutions, reliable support, and efficient procurement processes to its customers worldwide. Avantor's business model revolves around enabling scientific research and technological advancements through its extensive product offerings and industry expertise.
Avantor stock
Avantor Peer Group
Avantor Ticker
Avantor FIGI
All fundamentals and in-depth analysis of Avantor
Our stock analysis for Avantor Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avantor Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.